Medidata Solutions to Provide Clinical Data Management Expertise at 18th Annual DIA Euromeeting
FOR IMMEDIATE RELEASE
Medidata Solutions to Provide Clinical Data Management Expertise at
18th Annual DIA Euromeeting
Chief Medical Officer Ed Ikeguchi to Present on UK’s Nationwide EDC Deployment;
Senior Director Anne Zielinski to Highlight Data Integration Techniques
NEW YORK, NY – March 1, 2006 – Medidata Solutions, a global provider of electronic clinical data capture, management and reporting solutions, today announced that Chief Medical Officer Dr. Ed Ikeguchi and newly-appointed Senior Director of Strategic Alliances Anne Zielinski will each be presenting at the 18th Annual DIA EuroMeeting to be held March 6–8, 2006 at Le Palais des Congres in Paris, France.
Ikeguchi’s presentation, to be delivered on Wednesday, March 8th at 12:30 p.m., is entitled “The Deployment of Technology Platforms and Electronic Data Capture (EDC) on a National Level: Experience with the National Health Service (NHS) in the United Kingdom.” In this seminar, Ikeguchi will present a case study of the UK’s governmentsponsored effort to improve clinical trials quality and stimulate enrollment through the NHS and the National Cancer Research Network (NCRN). Ikeguchi plans to discuss how standardizing technology as a single platform across an entire nation requires unique considerations for successful implementation.
Zielinski’s presentation, “Importing and Exporting Data from EDC—Options and Experiences” on Wednesday, March 8th at 11:00 a.m., will illustrate how increased use of EDC has brought demands for integration of data from various sources. Attendees will learn how data has been integrated, what workflows have been used for integrated data, and how to avoid issues when integrating data.
At this year’s show, Medidata Solutions will also be demonstrating its Rave electronic clinical data management solution at booth #55. In addition to showcasing technologies like Rave, the conference will offer attendees an opportunity to learn about the challenges of the revised pharmaceutical legislation and witness the release of the latest developments in important initiatives in Europe.
As one of Medidata’s founders and the company’s Chief Medical Officer, Ikeguchi focuses on regulatory compliance and 21 CFR Part 11 and is responsible for ensuring defined project goals, objectives, development strategy, resource requirements and scheduling. Prior to forming Medidata Solutions in 2000, Ikeguchi served as assistant professor of clinical urology at Columbia University and held hospital appointments at Columbia Presbyterian, Helen Hayes Hospital and White Plains Hospitals Center. Ikeguchi has served as a clinical investigator in numerous trials sponsored by both the industry and NIH, with experience in technology-based processes related to the pharmaceutical and biotechnology industries. Ikeguchi is a regularly featured presenter at DIA and other industry events and was also named by PharmaVOICE as one of the industry’s most inspirational people and influential leader in the life sciences community.
Zielinski joined Medidata as senior director of strategic alliances in December of 2005. Zielinski had previously served as vice President of strategic alliances at CB Technologies and vice president of business development at WebMD. Zielinski brings 10 years of experience in the EDC industry and is a frequent presenter at key industry events including SCDM and DIA meetings.
About the Drug Information Association
With more than 22,000 members worldwide, the Drug Information Association (DIA) is the premier member driven organization encompassing the full continuum of disciplines in the pharmaceutical and related industries. The mission of the DIA is to serve and develop members by providing a neutral, global forum that promotes the exchange of information critical to professional performance and achievement. For further information, please visit www.diahome.org.
About Medidata Solutions Worldwide
Medidata Solutions helps the world’s leading pharmaceutical, biotechnology and medical device companies realize the maximum potential value from their clinical research investments. Working with companies large and small, Medidata Solutions helps accelerate the process of bringing life-enhancing treatments to market—on five continents and in more than 70 countries. Innovative process design, technology and services can streamline clinical trials by providing early visibility to clinical data for faster decision-making, optimized resources and lower execution risk. Medidata Solutions’ broad client base and deep clinical experience provide value for the world’s leading pharmaceutical, biotechnology and medical device companies, expertise in more than 20 therapeutic areas, projects in Phase I, II, III, IV, registries and surveillance, and studies with thousands of investigators and tens-of-thousands of subjects. To learn more about Medidata Solutions, please visit www.mdsol.com.
Contact:
Susan Lombardo
Lois Paul & Partners
781.782.5767
Susan_Lombardo@lpp.com